Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 1
2005 3
2006 1
2008 1
2009 6
2010 5
2011 8
2012 5
2013 9
2014 10
2015 8
2016 8
2017 11
2018 5
2019 12
2020 18
2021 22
2022 21
2023 27

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Results by year

Filters applied: . Clear all
Page 1
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups. Hauser SL, et al. N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246. N Engl J Med. 2020. PMID: 32757523 Clinical Trial.
Targeting B cells to modify MS, NMOSD, and MOGAD: Part 2.
Graf J, Mares J, Barnett M, Aktas O, Albrecht P, Zamvil SS, Hartung HP. Graf J, et al. Among authors: mares j. Neurol Neuroimmunol Neuroinflamm. 2020 Dec 16;8(1):e919. doi: 10.1212/NXI.0000000000000919. Print 2021 Jan. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 33411674 Free PMC article. Review.
Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis.
Montalban X, Arnold DL, Weber MS, Staikov I, Piasecka-Stryczynska K, Willmer J, Martin EC, Dangond F, Syed S, Wolinsky JS; Evobrutinib Phase 2 Study Group. Montalban X, et al. N Engl J Med. 2019 Jun 20;380(25):2406-2417. doi: 10.1056/NEJMoa1901981. Epub 2019 May 10. N Engl J Med. 2019. PMID: 31075187 Clinical Trial.
Crocosphaera watsonii.
Masuda T, Inomura K, Mareš J, Prášil O. Masuda T, et al. Among authors: mares j. Trends Microbiol. 2022 Aug;30(8):805-806. doi: 10.1016/j.tim.2022.02.006. Epub 2022 Mar 21. Trends Microbiol. 2022. PMID: 35331632 Free article. No abstract available.
Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP).
Butzkueven H, Kappos L, Wiendl H, Trojano M, Spelman T, Chang I, Kasliwal R, Jaitly S, Campbell N, Ho PR, Licata S; Tysabri Observational Program (TOP) Investigators. Butzkueven H, et al. J Neurol Neurosurg Psychiatry. 2020 Jun;91(6):660-668. doi: 10.1136/jnnp-2019-322326. Epub 2020 Mar 31. J Neurol Neurosurg Psychiatry. 2020. PMID: 32234967 Free PMC article.
Multiple sclerosis and COVID-19.
Mares J, Hartung HP. Mares J, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020 Sep;164(3):217-225. doi: 10.5507/bp.2020.033. Epub 2020 Jul 17. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020. PMID: 32686774 Free article. Review.
Trends in Neonatal Ophthalmic Screening Methods.
Hložánek M, Straňák Z, Terešková Z, Mareš J, Krejčířová I, Česká Burdová M. Hložánek M, et al. Among authors: mares j. Diagnostics (Basel). 2022 May 18;12(5):1251. doi: 10.3390/diagnostics12051251. Diagnostics (Basel). 2022. PMID: 35626406 Free PMC article. Review.
Drug Treatment of Clinically Isolated Syndrome.
Förster M, Graf J, Mares J, Aktas O, Hartung HP, Kremer D. Förster M, et al. Among authors: mares j. CNS Drugs. 2019 Jul;33(7):659-676. doi: 10.1007/s40263-019-00647-x. CNS Drugs. 2019. PMID: 31290079 Review.
168 results